￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Classification and treatment advantages of cobimetinib (cobimetinib) targeted drug and clinical research progress

2026-02-01 22:25:32

Check Details
Comparison of the differences between domestic and imported versions of macitentan and analysis of differences in efficacy

2026-02-01 22:25:32

Check Details
What are the common side effects of Tilorisen? Analysis of usage safety and precautions

2026-02-01 22:25:32

Check Details
A comprehensive guide to the common side effects and long-term safety of Pretomanid

2026-02-01 22:25:32

Check Details
Are there any risks with voclosporin soft capsule trial?

2026-02-01 22:25:32

Check Details
Clinical efficacy and resistance time of ponatinib

2026-02-01 22:25:32

Check Details
The efficacy and role of Shafinamide Tablets (Siddaco) and its long-term safety and precautions

2026-02-01 22:25:32

Check Details
Tarlatamab-Imdelltra manufacturer information and original research background analysis

2026-02-01 22:25:32

Check Details
Is telisotuzumab-EMRELIS a targeted drug?

2026-02-01 22:25:32

Check Details
Analysis of tovorafenib market price and reference information of regular drug purchase channels

2026-02-01 22:25:32

Check Details
Has vorasidenib-VORANIGO been included in medical insurance and reimbursement policies?

2026-02-01 22:25:32

Check Details
Indications, usage, dosage and precautions of Zongatinib (Zongatinib)

2026-02-01 22:25:32

Check Details
Category
相关知识